Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems - Qing Cai; Armita Azarpanah; Jayshil A. Bhatt; Hui Wei; Jamie Carr; Kenneth R. Morris; Caroline Strasinger; Nicole K. Brogden (Pharmaceutical Research, 2024)

Statistical Considerations in Assessing In Vivo Adhesion with Transdermal and Topical Delivery Systems for New Drug Applications - Chao Wang; Caroline Strasinger; Meiyu Shen; Yi Tsong (The AAPS Journal, 2020)

Determination of Rate and Extent of Scopolamine Release from Transderm Scōp® Transdermal Drug Delivery Systems in Healthy Human Adults - Suresh Kumar Swaminathan; Caroline Strasinger; Megan Kelchen; Jamie Carr; Wei Ye; Anna Wokovich; Priyanka Ghosh; Srinivasan Rajagopal; Kenichi Ueda; James Fisher; Karunya K. Kandimalla; Nicole K. Brogden (AAPS PharmSciTech, 2020)

The Sensitivity of In Vitro Permeation Tests to Chemical Penetration Enhancer Concentration Changes in Fentanyl Transdermal Delivery Systems - Soo Hyeon Shin; Jukkarin Srivilai; Sarah A. Ibrahim; Caroline Strasinger; Dana C. Hammell; Hazem E. Hassan; Audra L. Stinchcomb (AAPS PharmSciTech, 2018)

CDER Risk Assessment Exercise to Evaluate Potential Risks from the Use of Nanomaterials in Drug Products - Celia N. Cruz; Katherine M. Tyner; Lydia Velazquez; Kenneth C. Hyams; Abigail Jacobs; Arthur B. Shaw; Wenlei Jiang; Robert Lionberger; Peter Hinderling; Yoon Kong; Paul C. Brown; Tapash Ghosh; et al. (The AAPS Journal, 2013)